FDA-Drug2026-07-01Class IIPROCESSING DEFECT
Amgen Corlanor (ivabradine) 5 mg tablets recalled for foreign substance contamination
Nationwide distribution
Amgen Corlanor heart medication recalled for foreign substance
Amgen has recalled multiple lots of Corlanor (ivabradine) 5 mg tablets due to the presence of a foreign substance in some bottles. The affected tablets are packaged in 14-tablet and 60-tablet bottles distributed nationwide. No injuries have been reported.
- Check if your Corlanor matches one of the recalled lot numbers and expiration dates listed on the FDA website.
- Contact your pharmacy or doctor if you have an affected bottle.
- Do not use recalled tablets; return them to your pharmacy.
- Continue taking your heart medication as prescribed — talk to your doctor about next steps if your supply is affected.
Hazard
Presence of Foreign Substance.
Sold states
Nationwide within the United States
Affected count
934577 bottles
Manufactured in
1 Amgen Center Dr, N/A, Thousand Oaks, CA, United States
Products
Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC 55513-800-99), and b) 60 tablet bottles (NDC 55513-800-60), Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0612-2026More Amgen, Inc. recalls
- FDA-Drug2026-07-01Amgen Corlanor (ivabradine) 7.5mg tablets recalled for foreign substance
- FDA-Drug2026-07-01Amgen Sensipar 60mg tablets recalled for manufacturing quality deviations
- FDA-Drug2026-07-01Amgen Sensipar (cinacalcet) 90mg tablets recalled for manufacturing compliance issues
- FDA-Drug2026-07-01Amgen Sensipar (cinacalcet) 30mg tablets recalled for manufacturing quality deviations
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief